160 related articles for article (PubMed ID: 10737955)
1. Appropriate levels of cytotoxicity for genotoxicity tests using mammalian cells in vitro.
Müller L; Sofuni T
Environ Mol Mutagen; 2000; 35(3):202-5. PubMed ID: 10737955
[TBL] [Abstract][Full Text] [Related]
2. Analysis of published data for top concentration considerations in mammalian cell genotoxicity testing.
Parry JM; Parry E; Phrakonkham P; Corvi R
Mutagenesis; 2010 Nov; 25(6):531-8. PubMed ID: 20720196
[TBL] [Abstract][Full Text] [Related]
3. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes.
Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM
Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
Kirkland D; Aardema M; Henderson L; Müller L
Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
Kirkland D; Aardema M; Müller L; Makoto H
Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
[TBL] [Abstract][Full Text] [Related]
6. A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins.
Kirkland D; Reeve L; Gatehouse D; Vanparys P
Mutat Res; 2011 Mar; 721(1):27-73. PubMed ID: 21238603
[TBL] [Abstract][Full Text] [Related]
7. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
[TBL] [Abstract][Full Text] [Related]
8. Genetic toxicity assessment: employing the best science for human safety evaluation. Part II: Performances of the in vitro micronucleus test compared to the mouse lymphoma assay and the in vitro chromosome aberration assay.
Lorge E; Lambert C; Gervais V; Becourt-Lhote N; Delongeas JL; Claude N
Toxicol Sci; 2007 Apr; 96(2):214-7. PubMed ID: 17192442
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity and chromosome aberrations in vitro: experience in industry and the case for an upper limit on toxicity in the aberration assay.
Galloway SM
Environ Mol Mutagen; 2000; 35(3):191-201. PubMed ID: 10737954
[TBL] [Abstract][Full Text] [Related]
10. The in vivo comet assay: use and status in genotoxicity testing.
Brendler-Schwaab S; Hartmann A; Pfuhler S; Speit G
Mutagenesis; 2005 Jul; 20(4):245-54. PubMed ID: 15899933
[TBL] [Abstract][Full Text] [Related]
11. How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop.
Kirkland D; Pfuhler S; Tweats D; Aardema M; Corvi R; Darroudi F; Elhajouji A; Glatt H; Hastwell P; Hayashi M; Kasper P; Kirchner S; Lynch A; Marzin D; Maurici D; Meunier JR; Müller L; Nohynek G; Parry J; Parry E; Thybaud V; Tice R; van Benthem J; Vanparys P; White P
Mutat Res; 2007 Mar; 628(1):31-55. PubMed ID: 17293159
[TBL] [Abstract][Full Text] [Related]
12. Genetic toxicity assessment: employing the best science for human safety evaluation part III: the comet assay as an alternative to in vitro clastogenicity tests for early drug candidate selection.
Witte I; Plappert U; de Wall H; Hartmann A
Toxicol Sci; 2007 May; 97(1):21-6. PubMed ID: 17204584
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Vitotox and RadarScreen assays for the rapid assessment of genotoxicity in the early research phase of drug development.
Westerink WM; Stevenson JC; Lauwers A; Griffioen G; Horbach GJ; Schoonen WG
Mutat Res; 2009 May; 676(1-2):113-30. PubMed ID: 19393335
[TBL] [Abstract][Full Text] [Related]
14. Mutagenicity assessment of acrylate and methacrylate compounds and implications for regulatory toxicology requirements.
Johannsen FR; Vogt B; Waite M; Deskin R
Regul Toxicol Pharmacol; 2008 Apr; 50(3):322-35. PubMed ID: 18346829
[TBL] [Abstract][Full Text] [Related]
15. International Conference on Harmonisation; guidance on S2(R1) Genotoxicity Testing and Data Interpretation for Pharmaceuticals intended for Human Use; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2012 Jun; 77(110):33748-9. PubMed ID: 22675782
[TBL] [Abstract][Full Text] [Related]
16. Mouse lymphoma thymidine kinase gene mutation assay: follow-up International Workshop on Genotoxicity Test Procedures, New Orleans, Louisiana, April 2000.
Moore MM; Honma M; Clements J; Harrington-Brock K; Awogi T; Bolcsfoldi G; Cifone M; Collard D; Fellows M; Flanders K; Gollapudi B; Jenkinson P; Kirby P; Kirchner S; Kraycer J; McEnaney S; Muster W; Myhr B; O'Donovan M; Oliver J; Ouldelhkim MC; Pant K; Preston R; Riach C; San R; Shimada H; Stankowski LF
Environ Mol Mutagen; 2002; 40(4):292-9. PubMed ID: 12489120
[TBL] [Abstract][Full Text] [Related]
17. Genotoxicity and carcinogenicity studies of antihypertensive agents.
Brambilla G; Martelli A
Mutat Res; 2006 Mar; 612(2):115-49. PubMed ID: 16458045
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the genotoxic potential of the natural neurotoxin Tetrodotoxin (TTX) in a battery of in vitro and in vivo genotoxicity assays.
Guzmán A; Fernández de Henestrosa AR; Marín AP; Ho A; Borroto JI; Carasa I; Pritchard L
Mutat Res; 2007 Dec; 634(1-2):14-24. PubMed ID: 17881283
[TBL] [Abstract][Full Text] [Related]
19. [Genotoxicity study of Cortex Fraxini decoction].
Hu Y; Song J; Wang X; Zhang M; Wang X; Li B
Zhongguo Zhong Yao Za Zhi; 2009 Sep; 34(17):2228-31. PubMed ID: 19943492
[TBL] [Abstract][Full Text] [Related]
20. Development of genotoxicity test procedures with Episkin, a reconstructed human skin model: towards new tools for in vitro risk assessment of dermally applied compounds?
Flamand N; Marrot L; Belaidi JP; Bourouf L; Dourille E; Feltes M; Meunier JR
Mutat Res; 2006 Jul; 606(1-2):39-51. PubMed ID: 16675293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
